Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

178462 Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein

Native apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor for lipoprotein lipase.

Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: Apo C-II

178462
Purchase on Sigma-Aldrich

Panoramica

Replacement Information

Products

Numero di catalogoConfezionamento Qtà/conf
178462-50UG Fiala di plastica 50 μg
Description
OverviewNative apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor for lipoprotein lipase. Elevated serum levels of Apo C-II are common in type I, III, IV, and V hyperlipoproteinemia. Low serum concentrations of Apo C-II are indicative of nephrotic syndrome (Tangier’s Disease).
Catalogue Number178462
Brand Family Calbiochem®
SynonymsApo C-II
References
ReferencesBrunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.
Product Information
FormLyophilized
FormulationLyophilized from 10 mM NH₄HCO₃, pH 7.4.
Quality LevelMQ100
Applications
Biological Information
Purity≥95% by SDS-PAGE
SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage -20°C
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
178462-50UG 04055977205107

Documentation

Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein MSDS

Titolo

Scheda di sicurezza (MSDS) 

Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein Certificati d'Analisi

TitoloNumero di lotto
178462

Riferimenti bibliografici

Panoramica delle referenze
Brunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.
Scheda tecnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision15-April-2008 RFH
SynonymsApo C-II
DescriptionNative apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor of lipoprotein lipase. Elevated serum levels of Apo C-II are often present in type I, III, IV and V hyperlipoproteinemia. Low serum concentrations of Apo C-II are indicative of nephrotic syndrome (Tangier disease).
FormLyophilized
FormulationLyophilized from 10 mM NH₄HCO₃, pH 7.4.
SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
Purity≥95% by SDS-PAGE
SolubilityH₂O. Please refer to vial label for lot-specific volume prior to lyophilization.
Storage -20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Standard Handling
ReferencesBrunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.